A comprehensive gene expression signature has identified four major molecular subtypes: luminal A, luminal B, HER2-enriched and basal-like breast cancers, which are largely comprised of the triple negative breast cancer (TNBC) subtype. This evidence concerns the gene ERBB2 and breast cancer.